{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:37:47Z","timestamp":1793115467708,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T00:00:00Z","timestamp":1734825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejon.2024.102770","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T11:24:50Z","timestamp":1734780290000},"page":"102770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluation of therapy support through a standardized nursing consultation for patients undergoing oral tumor therapy in gynecological oncology within the prospective CAMPA initiative"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9613-4395","authenticated-orcid":false,"given":"Lisa","family":"Hirschberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Henze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Paradies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Schink\u00f6the","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Haidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Kates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lippach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Trillsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Theurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Wuerstlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejon.2024.102770_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ejon.2015.05.007","article-title":"Nurse-led outpatient clinics in oncology care \u2013 patient satisfaction, information and continuity of care","volume":"19","author":"Berglund","year":"2015","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"12","key":"10.1016\/j.ejon.2024.102770_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s40262-022-01167-6","article-title":"Pharmacokinetics and pharmacodynamics of PARP inhibitors in oncology","volume":"61","author":"Bruin","year":"2022","journal-title":"Clin. Pharmacokinet."},{"issue":"34","key":"10.1016\/j.ejon.2024.102770_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012037","article-title":"Nurse-led interventions on quality of life for patients with cancer: a meta-analysis","volume":"97","author":"Cheng","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.ejon.2024.102770_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ygyno.2023.05.065","article-title":"Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: results of a Delphi study","volume":"175","author":"Colombo","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ejon.2024.102770_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2021.07.016","article-title":"Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial","volume":"163","author":"Colombo","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ejon.2024.102770_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000535997","article-title":"ABC7 consensus: assessment by a German group of experts","volume":"19","author":"Ditsch","year":"2024","journal-title":"Breast Care"},{"key":"10.1016\/j.ejon.2024.102770_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628690","article-title":"Activation of PI3K\/AKT\/mTOR pathway causes drug resistance in breast cancer","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejon.2024.102770_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.colegn.2017.10.011","article-title":"Nurse-led services in Queensland: a scoping study","volume":"25","author":"Douglas","year":"2018","journal-title":"Collegian"},{"issue":"1","key":"10.1016\/j.ejon.2024.102770_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","article-title":"Using the common Terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"issue":"12","key":"10.1016\/j.ejon.2024.102770_bib10","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.ejon.2024.102770_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.annonc.2023.05.003","volume":"34","author":"Harbeck","year":"2023","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.ejon.2024.102770_bib12","first-page":"42","article-title":"Pflegeexpertinnen begleiten orale Tumortherapie","volume":"60","author":"Harbeck","year":"2022","journal-title":"Schwest. - Pfleg."},{"issue":"5","key":"10.1016\/j.ejon.2024.102770_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s15015-023-3267-2","article-title":"Interprofessionelles Management der oralen Tumortherapie","volume":"26","author":"Henze","year":"2023","journal-title":"Im Fokus Onkologie"},{"issue":"6","key":"10.1016\/j.ejon.2024.102770_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s15004-019-6582-1","article-title":"Wandel der ambulanten onkologischen Versorgung und die Folgen","volume":"22","author":"Hermes-Moll","year":"2019","journal-title":"Info H\u00e4matologie und Onkologie"},{"key":"10.1016\/j.ejon.2024.102770_bib15","article-title":"What are needs in oral anti-tumor therapy? An analysis of patients' and practitioners' preferences","volume":"14","author":"Hester","year":"2024","journal-title":"Front. Oncol. Sec. Breast Cancer"},{"issue":"9","key":"10.1016\/j.ejon.2024.102770_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000501725","article-title":"Feasibility of nurse consultation in oral tumor therapy: a web-based survey among physicians and nonmedical specialists","volume":"42","author":"Kaiser","year":"2019","journal-title":"Oncol. Res. Treat."},{"issue":"7","key":"10.1016\/j.ejon.2024.102770_bib17","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/jog.15965","article-title":"Olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer at a single institution: a retrospective study","volume":"50","author":"Katsuda","year":"2024","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ejon.2024.102770_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2020.101780","article-title":"Effects of a nurse-led medication self-management programme in women with oral treatments for metastatic breast cancer: a mixed-method randomised controlled trial","volume":"47","author":"Komatsu","year":"2020","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"1","key":"10.1016\/j.ejon.2024.102770_bib19","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/S1470-2045(18)30786-1","article-title":"Exploring and comparing adverse events between PARP inhibitors","volume":"20","author":"LaFargue","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejon.2024.102770_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2288-7-30","article-title":"The Hawthorne Effect: a randomised, controlled trial","volume":"7","author":"McCarney","year":"2007","journal-title":"BMC Med. Res. Methodol."},{"issue":"7","key":"10.1016\/j.ejon.2024.102770_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/oncolo\/oyad123","article-title":"Adjuvant olaparib for germline BRCA carriers with HER2-negative early breast cancer: evidence and controversies","volume":"28","author":"Morganti","year":"2023","journal-title":"Oncol."},{"key":"10.1016\/j.ejon.2024.102770_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918808509","article-title":"Inhibitors targeting CDK4\/6, PARP and PI3K in breast cancer: a review","volume":"10","author":"Nur Husna","year":"2018","journal-title":"Therapeutic advances in medical oncology"},{"issue":"4","key":"10.1016\/j.ejon.2024.102770_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000531578","article-title":"Arbeitsgemeinschaft gyn\u00e4kologische onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023","volume":"18","author":"Park-Simon","year":"2023","journal-title":"Breast Care"},{"issue":"11","key":"10.1016\/j.ejon.2024.102770_bib24","first-page":"3475","article-title":"Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial","volume":"25","author":"Riese","year":"2017","journal-title":"Support. Care Cancer"},{"issue":"4","key":"10.1016\/j.ejon.2024.102770_bib25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/annonc\/mdz012","article-title":"OlympiAD final overall survival and tolerability results: olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer","volume":"30","author":"Robson","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejon.2024.102770_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.01447","article-title":"Nurse-led individualized follow-up versus regular physician-led visits after early breast cancer (MyHealth): a phase III randomized, controlled trial","author":"Saltb\u00e6k","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"46","key":"10.1016\/j.ejon.2024.102770_bib27","first-page":"775","article-title":"New oral anti-cancer drugs and medication safety","volume":"116","author":"Schlichtig","year":"2019","journal-title":"Deutsches Arzteblatt international"},{"issue":"4","key":"10.1016\/j.ejon.2024.102770_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000531579","article-title":"AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023","volume":"18","author":"Thill","year":"2023","journal-title":"Breast Care"},{"issue":"6","key":"10.1016\/j.ejon.2024.102770_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s41906-021-1043-5","article-title":"Orale tumortherapie beim mammakarzinom","volume":"74","author":"Travi","year":"2021","journal-title":"Pflegezeitschrift"},{"issue":"Suppl. 3","key":"10.1016\/j.ejon.2024.102770_bib30","first-page":"1","article-title":"NCCN task force report: oral chemotherapy","volume":"6","author":"Weingart","year":"2008","journal-title":"J. Natl. Compr. Cancer Netw.: J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ejon.2024.102770_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.annonc.2023.09.555","volume":"34","author":"Welslau","year":"2023","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ejon.2024.102770_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s15015-022-3815-1","article-title":"OncoCoaching - eine patientenzentrierte Versorgung in der Onkologie","volume":"25","author":"Welslau","year":"2022","journal-title":"Im Fokus Onkologie"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388924002680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388924002680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T21:16:30Z","timestamp":1758834990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388924002680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":32,"alternative-id":["S1462388924002680"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2024.102770","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of therapy support through a standardized nursing consultation for patients undergoing oral tumor therapy in gynecological oncology within the prospective CAMPA initiative","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2024.102770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102770"}}